ERASMUS MC BIOMEDICAL FUND
Erasmus MC Biomedical Fund finances early-stage companies in the biotechnology and biomedical field and is an independent investment firm. The Erasmus MC Biomedical Fund is a specialist fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns.
ERASMUS MC BIOMEDICAL FUND
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta LetsEncrypt Apple Mobile Web Clips Icon Apache Wordpress Plugins Google Apps For Business Contact Form 7 WordPress 4.0
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2011-12-01 | arGEN-X | Erasmus MC Biomedical Fund investment in Series B - arGEN-X | 32.5 M EUR |
| 2010-02-11 | arGEN-X | Erasmus MC Biomedical Fund investment in Series A - arGEN-X | 4.5 M USD |
| 2009-09-10 | arGEN-X | Erasmus MC Biomedical Fund investment in Series A - arGEN-X | 13.6 M USD |
| 2009-05-26 | Cavadis | Erasmus MC Biomedical Fund investment in Series A - Cavadis | N/A |
| 2008-04-01 | Therosteon | Erasmus MC Biomedical Fund investment in Venture Round - Therosteon | N/A |
| 2007-12-20 | RiverD International | Erasmus MC Biomedical Fund investment in Venture Round - RiverD International | N/A |